Cross Reactive Epitope Group antibodies in sensitized kidneys transplant recipients was associated with early acute Antibody Mediated Rejection (Q79815538)

From Wikidata

Jump to navigation Jump to search

scientific article published on 06 November 2008

Language	Label	Description	Also known as
English	Cross Reactive Epitope Group antibodies in sensitized kidneys transplant recipients was associated with early acute Antibody Mediated Rejection	scientific article published on 06 November 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Cross Reactive Epitope Group antibodies in sensitized kidneys transplant recipients was associated with early acute Antibody Mediated Rejection (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Neha Nainani

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Thomas Shanahan

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Amar Damodar

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Nakul Parimoo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sudheer Ummadi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yasir Qazi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Brian M Murray

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Kathleen M Tornatore

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

James C Ciccirella

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

George A Blessios

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Rocco C Venuto

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

6 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Transplant Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

113-117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Kidney and pancreas transplantation in the United States, 1996-2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to nonsensitized recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

New immunosuppressants and HLA matching

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA)

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

National conference to assess antibody-mediated rejection in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Presensitization: the problem and its management

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Effect of HLA-DR and class I cross-reactive group matching on first cardiac transplants: an analysis of access and outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Banff 07 classification of renal allograft pathology: updates and future directions

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

The effect of HLA-A, -B matching on cadaver renal allograft rejection comparing public and private specificities

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Equitable allocation of HLA-compatible kidneys for local pools and for minorities

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

HLA and cross-reactive antigen group matching for cadaver kidney allocation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

An evaluation of HLA cross-reactive group matching on graft survival in deceased donor kidney recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Immunological relevance of CREG matching in cadaver kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Relevance of posttransplant HLA class I and class II antibodies on renal graft outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

The clinical importance of alloantibody-mediated rejection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Overcoming a positive crossmatch in living-donor kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Rituximab and intravenous immune globulin for desensitization during renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Rituximab therapy for acute humoral rejection after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Drug insight: rituximab in renal disease and transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

The use of Campath-1H as induction therapy in renal transplantation: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2008.10.009

7 January 2021

Identifiers

10.1016/J.TRIM.2008.10.009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996198%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79815538&oldid=2215769662"